Anti-alphavbeta1 integrin inhibitors and methods of use
US10214522B2 · kind B2 · utility
13Cited by
14References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 10, 2016 |
| Grant date | Feb 26, 2019 |
| Priority date | — |
| Expiry date | Mar 10, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/7055
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Provided herein, inter alia, are methods and compositions for inhibiting αvβ1 integrin and for treating fibrosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.